The Chemistry and Pharmaceutical sciences group at Vrije Universiteit Amsterdam (VU) has recently rejoined Innovation Lab Chemistry (ILCA), which provides innovation support to chemical companies, supported by various organisations in the region. With this participation, the VU hopes to contribute new knowledge and expertise in addition to the existing universities that are already part of the Innovation Lab.
At ILCA it is seen as good news: “We are very pleased that VU adds their Pharmaceutical chemistry knowledge to the portfolio of expertise of ILCA. This means that companies and organizations in the MRA can benefit from a broader range of services to support their innovations and operational challenges”, says Willem Fokkema, director at ILCA.
The participation of VU will be coordinated by IXA-VU. “We make sure that questions from companies arrive on the right place” adds Ties van Rappard, business developer at VU. “We have extensive pharmaceutical expertise and (analytical) infrastructure in the labs of Prof Tom Grossmann useful for Lifesciences startup companies but also for mature companies in need for specific instruments. Regardless the question; analysis or synthesis. We find solutions”.
UvA spin-off SusPhos has been selected for the EIC Accelerator funding. They receive a grant and an equity investment from the EU fund for its game-changing solution for upcycling phosphate from waste streams into sustainable products. SusPhos, now based in Leeuwarden, aims to create “urban mines” in Europe to produce phosphate compounds out of waste. […]News
VU start-up, PreActive, has been awarded the MIT Feasibility Study subsidy of € 20k from Provincie Noord-Holland! With this subsidy funding PreActive will explore the utility and feasibility of incorporating Artificial Intelligence within the PreActive wellness app to help improve & personalise the user experience. Feasibility study of the Wellness app The PreActive Wellness app […]News
A smart swimming cap with electrodes can diagnose a stroke in the ambulance, so that a patient receives the correct treatment more quickly.News